|
⚲
|
| Keyboard |
| Kolaja Carey OConnor
✚
|
|
|---|---|
| CIK # | 0001848717 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001848717] | |
| 4 | [0001848717] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Revance Therapeutics Inc | |
| Kolaja Carey OConnor |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 15,000 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 16,561 | $3.65 | 60,448 |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2024-05-01 | Grant | 23,458 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-05-01 | Grant | 15,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-06-15 | Sell | 2,500 | $28.24 | 70,600 |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2023-06-15 | Option exercise | 2,500 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-06-15 | Option exercise | 2,500 | $18.12 | 45,300 |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2023-05-03 | Grant | 5,915 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-05-03 | Grant | 3,534 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2022-05-04 | Grant | 11,343 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2022-05-04 | Grant | 6,059 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-05-05 | Grant | 674 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2021-05-05 | Grant | 1,268 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-03-01 | Grant | 6,294 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2021-03-01 | Grant | 11,417 | $0.00 |